Formulating Drugs for Inhalers and Stability Issues
The main topic addressed in this paper is the formulation of pressurised metered dose inhalers and the problems associated with formulating medications for high pressure systems. Formulations for pressurised metered-dose inhalers (pMDIs) generally consist of two main types, solution and suspension-b...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
al-Farabi Kazakh National University
2012-11-01
|
Series: | Eurasian Chemico-Technological Journal |
Online Access: | http://ect-journal.kz/index.php/ectj/article/view/410 |
id |
doaj-840f1424b1034f2a83d74a29481a82b4 |
---|---|
record_format |
Article |
spelling |
doaj-840f1424b1034f2a83d74a29481a82b42020-11-24T21:01:22Zengal-Farabi Kazakh National UniversityEurasian Chemico-Technological Journal 1562-39202522-48672012-11-0114427128610.18321/ectj124410Formulating Drugs for Inhalers and Stability IssuesR. C. Toon0E. C. Preedy1P. Prokopovich2Nemaura Pharma Limited, Holywell Park, Loughborough, LE11 3AQ, UKSchool of Pharmacy and Pharmaceutical Sciences and School of Engineering, Cardiff University, Cardiff, CF10 3NB, UKSchool of Pharmacy and Pharmaceutical Sciences and School of Engineering, Cardiff University, Cardiff, CF10 3NB, UKThe main topic addressed in this paper is the formulation of pressurised metered dose inhalers and the problems associated with formulating medications for high pressure systems. Formulations for pressurised metered-dose inhalers (pMDIs) generally consist of two main types, solution and suspension-based systems. In the latter version, the active ingredient ideally remains mainly in the solid state, which can thus reduce problems with chemical degradation. However, the physical stability of such systems, in terms of aggregation, flocculation, creaming, sedimentation, propellant clathrates and bridging can then become problematic. The problems associated with solution-based systems revolve around the chemical stability of the active ingredients.http://ect-journal.kz/index.php/ectj/article/view/410 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
R. C. Toon E. C. Preedy P. Prokopovich |
spellingShingle |
R. C. Toon E. C. Preedy P. Prokopovich Formulating Drugs for Inhalers and Stability Issues Eurasian Chemico-Technological Journal |
author_facet |
R. C. Toon E. C. Preedy P. Prokopovich |
author_sort |
R. C. Toon |
title |
Formulating Drugs for Inhalers and Stability Issues |
title_short |
Formulating Drugs for Inhalers and Stability Issues |
title_full |
Formulating Drugs for Inhalers and Stability Issues |
title_fullStr |
Formulating Drugs for Inhalers and Stability Issues |
title_full_unstemmed |
Formulating Drugs for Inhalers and Stability Issues |
title_sort |
formulating drugs for inhalers and stability issues |
publisher |
al-Farabi Kazakh National University |
series |
Eurasian Chemico-Technological Journal |
issn |
1562-3920 2522-4867 |
publishDate |
2012-11-01 |
description |
The main topic addressed in this paper is the formulation of pressurised metered dose inhalers and the problems associated with formulating medications for high pressure systems. Formulations for pressurised metered-dose inhalers (pMDIs) generally consist of two main types, solution and suspension-based systems. In the latter version, the active ingredient ideally remains mainly in the solid state, which can thus reduce problems with chemical degradation. However, the physical stability of such systems, in terms of aggregation, flocculation, creaming, sedimentation, propellant clathrates and bridging can then become problematic. The problems associated with solution-based systems revolve around the chemical stability of the active ingredients. |
url |
http://ect-journal.kz/index.php/ectj/article/view/410 |
work_keys_str_mv |
AT rctoon formulatingdrugsforinhalersandstabilityissues AT ecpreedy formulatingdrugsforinhalersandstabilityissues AT pprokopovich formulatingdrugsforinhalersandstabilityissues |
_version_ |
1716778278257164288 |